SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-016547
Filing Date
2022-01-25
Accepted
2022-01-25 08:01:03
Documents
13
Period of Report
2022-01-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d263259d8k.htm   iXBRL 8-K 26822
2 EX-10.1 d263259dex101.htm EX-10.1 26931
  Complete submission text file 0001193125-22-016547.txt   188165

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA phat-20220119.xsd EX-101.SCH 2875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20220119_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20220119_pre.xml EX-101.PRE 11720
7 EXTRACTED XBRL INSTANCE DOCUMENT d263259d8k_htm.xml XML 3476
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 22551150
SIC: 2834 Pharmaceutical Preparations